{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT04119050: Phase 2/Phase 3 Interventional Recruiting Warm Autoimmune Hemolytic Anemia
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03821233: Phase 1 Interventional Completed HER2-expressing Cancers
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02664415: Phase 2 Interventional Completed HIV Infections
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03196219: Phase 2 Interventional Completed Dental Caries
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03508453: Phase 2 Interventional Withdrawn Amyotrophic Lateral Sclerosis
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:riliprubart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:dafsolimab setaritox [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:verzistobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:rosopatamab tetraxetan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02357966: Phase 1/Phase 2 Interventional Completed Staphylococcus Aureus Bacteremia
(2015)
Source URL:
Class:
PROTEIN
